Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui Province, China.
The Key Laboratory of Anti-inflammatory and Immune medicines, Ministry of Education, Hefei, Anhui, China.
Hum Cell. 2020 Oct;33(4):946-953. doi: 10.1007/s13577-020-00409-8. Epub 2020 Aug 9.
Long noncoding RNA (lncRNA) is a newly identified type of noncoding RNA with a length of more than 200 nucleotides. The latest research shows that lncRNAs play important roles in the occurrence and development of human tumours by acting both as carcinogenic genes and as tumour suppressor genes. LncRNAs plays a role in various biological processes, such as cell growth, apoptosis, migration and invasion. The newly discovered lncRNA DDX11-AS1 is abnormally highly expressed in various malignant tumours, such as hepatocellular carcinoma, colorectal cancer, osteosarcoma, bladder cancer, NSCLC and gastric cancer. DDX11-AS1 mainly regulates the expression of related genes through direct or indirect ways to perform its functions in carcinogenicity. These results indicate that DDX11-AS1 may be a marker or therapeutic target of tumours. This review summarizes the biological function and mechanism of DDX11-AS1 in the process of tumour development.
长链非编码 RNA(lncRNA)是一种新发现的非编码 RNA,长度超过 200 个核苷酸。最新研究表明,lncRNAs 通过作为致癌基因和抑癌基因发挥作用,在人类肿瘤的发生和发展中发挥重要作用。lncRNAs 在细胞生长、凋亡、迁移和侵袭等各种生物学过程中发挥作用。新发现的 lncRNA DDX11-AS1 在多种恶性肿瘤中异常高表达,如肝癌、结直肠癌、骨肉瘤、膀胱癌、非小细胞肺癌和胃癌。DDX11-AS1 主要通过直接或间接方式调节相关基因的表达,从而在致癌性中发挥其功能。这些结果表明,DDX11-AS1 可能是肿瘤的标志物或治疗靶点。本综述总结了 DDX11-AS1 在肿瘤发展过程中的生物学功能和机制。